ebastine has been researched along with Osteosarcoma in 1 studies
Osteosarcoma: A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pan, Z | 1 |
| Li, SJ | 1 |
| Guo, H | 1 |
| Li, ZH | 1 |
| Fei, X | 1 |
| Chang, SM | 1 |
| Yang, QC | 1 |
| Cheng, DD | 1 |
1 other study available for ebastine and Osteosarcoma
| Article | Year |
|---|---|
Ebastine exerts antitumor activity and induces autophagy by activating AMPK/ULK1 signaling in an IPMK-dependent manner in osteosarcoma.
Topics: AMP-Activated Protein Kinases; Autophagy; Autophagy-Related Protein-1 Homolog; Bone Neoplasms; Hista | 2023 |